LON:AVO Advanced Oncotherapy (AVO) Share Price, News & Analysis → RSVP: Charles Payne’s Cash Flow Workshop (From Unstoppable Prosperity) (Ad) Free AVO Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range 1.75▼ 1.7552-Week Range N/AVolume200,000 shsAverage Volume1.27 million shsMarket Capitalization£9.50 millionP/E RatioN/ADividend Yield5.49%Price TargetN/A Stock AnalysisStock AnalysisInsider TradesStock AnalysisInsider Trades Get Advanced Oncotherapy alerts: Email Address Ad Daily Market AlertsTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world's most powerful tech companies (including Microsoft, Intel, and Google) investing billions. And one tiny company will be the driving force behind this new tech revolution…Click below for your free report "Top 5 Tech Stocks to Buy in 2024", About Advanced Oncotherapy Stock (LON:AVO)Advanced Oncotherapy plc, together with its subsidiaries, engages in designing, assembling, and selling proton-based radiotherapy systems for treatment of cancer. It is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer. The company also engages in the management of healthcare related properties. It has operations in the United Kingdom, Switzerland, and the United States. The company was formerly known as CareCapital Group plc and changed its name to Advanced Oncotherapy PLC in September 2012. Advanced Oncotherapy plc was founded in 1994 and is headquartered in London, the United Kingdom.Read More Ad Daily Market AlertsTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world's most powerful tech companies (including Microsoft, Intel, and Google) investing billions. And one tiny company will be the driving force behind this new tech revolution…Click below for your free report "Top 5 Tech Stocks to Buy in 2024", AVO Stock News HeadlinesJune 1, 2024 | americanbankingnews.comAdvanced Oncotherapy (LON:AVO) Stock Crosses Below Two Hundred Day Moving Average of $1.75January 23, 2024 | lse.co.ukAdvanced Oncotherapy Share ChatDecember 9, 2023 | morningstar.comAdvanced Oncotherapy PLC AVOJune 12, 2023 | finance.yahoo.comFavourable Signals For Advanced Oncotherapy: Numerous Insiders Acquired StockJune 12, 2023 | finance.yahoo.comFavourable Signals For Advanced Oncotherapy: Numerous Insiders Acquired Stock \January 27, 2023 | finanznachrichten.deHardman & Co Research: Q&A on Advanced Oncotherapy (AVO): Current EV significantly below cumulative investment to dateJanuary 3, 2023 | finance.yahoo.comIndependent Non-Executive Director Michael Bradfield Just Bought 6.4% More Shares In Advanced Oncotherapy plc (LON:AVO)December 13, 2022 | marketwatch.comAdvanced Oncotherapy Raises GBP1.5 Mln Via High-Premium Share SubscriptionOctober 27, 2022 | proactiveinvestors.comProactive news headlines: Deepverge, Greatland Gold, Seeing Machines, and moreSeptember 29, 2022 | uk.finance.yahoo.comHardman & Co Research on Advanced Oncotherapy: Major milestone achievedSeptember 8, 2022 | finance.yahoo.comAdvanced Oncotherapy plc (LON:AVO) has caught the attention of institutional investors who hold a sizeable 39% stakeAugust 1, 2022 | finance.yahoo.comIs Now An Opportune Moment To Examine Advanced Oncotherapy plc (LON:AVO)?July 2, 2022 | finance.yahoo.comCalculating The Intrinsic Value Of Advanced Oncotherapy plc (LON:AVO)March 31, 2022 | proactiveinvestors.comAdvanced Oncotherapy's technology can slash costs of proton therapy cancer treatment says CEOMarch 26, 2022 | proactiveinvestors.com.auProactive weekly mining highlights: Horizonte, Atlantic Lithium, East Star and moreMarch 25, 2022 | proactiveinvestors.comAdvanced Oncotherapy raises £2mln at a premiumMarch 1, 2022 | proactiveinvestors.comFTSE 100 in the red as fighting in Ukraine is intensifying with RussiaMarch 1, 2022 | proactiveinvestors.comAdvanced Oncotherapy hails significant progress with regulatory submission as it updates on its timelineFebruary 25, 2022 | finance.yahoo.comAdvanced Oncotherapy plc (AVO.L)December 13, 2021 | proactiveinvestors.comAdvanced Oncotherapy says it is making good progress, but confirms previously-flagged delayNovember 15, 2021 | markets.businessinsider.comHardman & Co Research: Advanced Oncotherapy (AVO): On the home straightOctober 2, 2021 | finance.yahoo.comIs Advanced Oncotherapy plc (LON:AVO) Popular Amongst Insiders?September 2, 2021 | proactiveinvestors.comAdvanced Oncotherapy - Result of GM, TVR and clarification re warrantsAugust 12, 2021 | markets.businessinsider.comAdvanced Oncotherapy : Result of AGMAugust 12, 2021 | finanznachrichten.deHardman & Co Research: Advanced Oncotherapy (AVO) Funded to completionSee More Headlines Receive AVO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Advanced Oncotherapy and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings6/29/2020Today6/09/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolLON:AVO CUSIPN/A CIKN/A Webwww.advancedoncotherapy.com Phone+44-20-36178728FaxN/AEmployees174Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.07) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-32,600,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-67.34% Return on Assets-11.73% Debt Debt-to-Equity Ratio98.71 Current Ratio1.26 Quick Ratio0.13 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash Flow33.50 Book ValueGBX 14 per share Price / BookN/AMiscellaneous Outstanding Shares542,570,000Free FloatN/AMarket Cap£9.50 million OptionableNot Optionable Beta0.06 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesDr. Michael Jeffrey Sinclair (Age 82)Executive Chairman Comp: $434.42kMr. Nicolas Serandour (Age 49)CEO & Executive Director Comp: $502.96kProf. Stephen Myers OBE (Age 78)Executive Director Comp: $397.72kMr. Ed LeeCOO & President of EuropeMr. Graham PugheSenior Vice-President of AccountingMs. Berengere Pons-ChabordSenior Vice-President of Corporate FinanceMr. David NavasVice President of Investor and Public RelationsMs. Bridget BiggarDirector of Human ResourcesMs. Donatella UngaroManaging Director of ADAMMs. Marina GiuntaHead of Physics GroupMore ExecutivesKey CompetitorsIntelligent Ultrasound GroupLON:IUGBelluscuraLON:BELLInspiration Healthcare GroupLON:IHCRUA Life SciencesLON:RUAMyHealthCheckedLON:MHCView All Competitors AVO Stock Analysis - Frequently Asked Questions How were Advanced Oncotherapy's earnings last quarter? Advanced Oncotherapy plc (LON:AVO) posted its quarterly earnings results on Monday, June, 29th. The company reported ($9.83) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($8.90) by $0.93. What other stocks do shareholders of Advanced Oncotherapy own? Based on aggregate information from My MarketBeat watchlists, some companies that other Advanced Oncotherapy investors own include UK Oil & Gas (UKOG), Oxford Biomedica (OXB), BMR Group (BMR), GW Pharmaceuticals (GWPH), Lancashire (LRE), Sirius Minerals (SXX), Renishaw (RSW), Scancell (SCLP) and Tullow Oil (TLW). How do I buy shares of Advanced Oncotherapy? Shares of AVO stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:AVO) was last updated on 6/9/2024 by MarketBeat.com Staff From Our PartnersCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | SponsoredMajor Elon Musk Crypto Leak RevealedReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto mark...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Advanced Oncotherapy plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Advanced Oncotherapy With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.